Lund, Sweden, 04 April 2018
TFS International to Strengthen Strategic Planning Capabilities with Citeline Deal
TFS International, a leading, mid-sized clinical Contract Research Organization (CRO) is dedicated to the innovative use of technology to advance clinical development.
TFS Chief Medical Officer, Dr Bassem Saleh, has announced an agreement with the Pharma Intelligence division of Informa for their industry-leading, global research and development (R&D) platform - Citeline.
“At TFS we are already proud of the strategic and operational services that we provide our biotechnology and pharma clients.” said Dr Saleh. “This agreement with Citeline will take us to the next level and provide the strategy and operational team’s access to global, R&D intelligence platforms on a par with the largest CRO organizations.”
The services provided by Citeline will allow TFS to:-
- Maximize data analytics to create effective study strategies including country/site strategies and enrollment modelling.
- Perform comprehensive Endpoint analysis to recommend robust endpoints for clinical trial design
- Gain access to country specific enrollment benchmarks and patient data to facilitate selection of the best sites and ensure recruitment timelines are met
- Assess target locations and identify and prioritize qualified investigators and sites due to a database of over 400,000
…and much more.
Dr Saleh concludes “Citeline is the industry’s most comprehensive, reliable and current global R&D intelligence suite of solutions. Along with my IT colleagues, we are always looking for the industry-leading technologies to drive TFS forward, and with Citeline we are demonstrating exactly that.”
The importance of this Citeline and other technology investments to TFS was highlighted by Chief Executive Officer, János Filakovský, “We are very excited about our cooperation with Citeline. We will continue to invest in industry leading technologies, and in our people to provide innovative, data-driven productive solutions to our global customers.”
Citeline, part of Informa’s Pharma Intelligence vertical, is the world’s most comprehensive source of real-time R&D intelligence for the pharmaceutical industry, featuring an unmatched intelligence collection and enrichment of global clinical trials, clinical trial investigator profiles and drug development pipelines.
Citeline is the R&D Intelligence arm of Informa’s Pharma Intelligence vertical, one of the world’s leading providers of drug, device, company, clinical trial and market intelligence in the pharma and medtech markets. For more information, visit pharmaintelligence.informa.com.
About TFS International
TFS International is a leading, mid-size clinical Contract Research Organization providing global clinical development solutions. Founded in 1996 in Sweden, TFS currently operates in 21 countries throughout Europe and North America and employs more than 700 professionals. TFS’ core therapeutic areas of expertise are oncology, dermatology, ophthalmology, immunology, cardiology, CNS and endocrinology. Through two business areas, TFS Develop™ and TFS People™, TFS provides end-to-end solutions and tactical functional services throughout the world.
For further information, please contact:
Andy Waiton, Director – Marketing & Communications, Phone: +46 46 280 18 00
Detailed information about TFS can be obtained @ www.tfscro.com